Culturing antitumor T cells or CAR-T cells in IL-7 or IL-15 rather than IL-2 alone has been demonstrated to produce cells with greater in vivo tumor control and greater preservation of Tscm phenotype (56–58). The gene discussed is IL7; the disease is neoplasm.